FDA, Amadix

La FDA otorga la designación de dispositivo innovador al análisis de sangre de Amadix

Published on 08/07/2025 at 18:03 | prnewswire.co.uk

Amadix United Kingdom United States of America France Germany Spain California

en | boerse | 67998928 |